Citadel Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79M | Buy |
|
|||||
|
2025
Q1 | $57.8M | Sell |
|
|||||
|
2024
Q4 | $118M | Sell |
|
|||||
|
2024
Q3 | $117M | Buy |
|
|||||
|
2024
Q2 | $99.6M | Sell |
|
|||||
|
2024
Q1 | $116M | Buy |
|
|||||
|
2023
Q4 | $121M | Sell |
|
|||||
|
2023
Q3 | $116M | Buy |
|
|||||
|
2023
Q2 | $103M | Sell |
|
|||||
|
2023
Q1 | $62.5M | Buy |
|
|||||
|
2022
Q4 | $30.3M | Buy |
|
|||||
|
2022
Q3 | $21.4M | Sell |
|
|||||
|
2022
Q2 | $13.9M | Buy |
|
|||||
|
2022
Q1 | $7.76M | Buy |
|
|||||
|
2021
Q4 | $6.6M | Hold |
|
|||||
|
2021
Q3 | $6.77M | Sell |
|
|||||
|
2021
Q2 | $7.15M | Sell |
|
|||||
|
2021
Q1 | $7.07M | Buy |
|
|||||
|
2020
Q4 | $7.44M | Buy |
|